Maximizing computational tools for successful drug discovery

Drug discovery is an iterative cycle of identifying promising hits followed by lead optimization via bioisosteric replacements. In the search for compounds affording good bioactivity, equal importance should also be placed on achieving those with favorable pharmacokinetic properties. Thus, the balance and realization of both key properties is an intricate problem that requires great caution. In this editorial, the authors explore the available computational tools in the context of the extant of big data that has borne out via advents of the Omics revolution. As such, the selection of appropriate computational tools for analyzing the vast number of chemical libraries, target proteins and interactomes is the first step toward maximizing the chance for success. However, in order to realize this, it is also necessary to have a solid foundation on the big concepts of drug discovery as well as knowing which tools are available in order to give drug discovery scientists the best opportunity.

[1]  S. Rees,et al.  Principles of early drug discovery , 2011, British journal of pharmacology.

[2]  Jordi Mestres,et al.  PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery , 2012, Molecular informatics.

[3]  Qian Li,et al.  Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines , 2012, Journal of Cheminformatics.

[4]  Olivier Sperandio,et al.  One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade. , 2013, Drug discovery today.

[5]  Michael Nilges,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btl655 Structural bioinformatics Biskit—A software platform for structural bioinformatics , 2006 .

[6]  F. Iorio,et al.  Transcriptional data: a new gateway to drug repositioning? , 2013, Drug discovery today.

[7]  James McKay,et al.  A universal open-source Electronic Laboratory Notebook , 2013, Bioinform..

[8]  Reinhard Schneider,et al.  Using graph theory to analyze biological networks , 2011, BioData Mining.

[9]  Noel M. O'Boyle,et al.  Cinfony – combining Open Source cheminformatics toolkits behind a common interface , 2008, Chemistry Central journal.

[10]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[11]  Adel Hamza,et al.  SABRE: Ligand/Structure-Based Virtual Screening Approach Using Consensus Molecular-Shape Pattern Recognition , 2014, J. Chem. Inf. Model..

[12]  Yang Zhang.  Progress and challenges in protein structure prediction. , 2008, Current opinion in structural biology.

[13]  J. Medina-Franco,et al.  Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.

[14]  Egon L. Willighagen,et al.  Towards interoperable and reproducible QSAR analyses: Exchange of datasets , 2010, J. Cheminformatics.

[15]  M. Stahl,et al.  Scaffold hopping. , 2004, Drug discovery today. Technologies.

[16]  Dan Li,et al.  ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates. , 2014, Molecular pharmaceutics.

[17]  Anton Nekrutenko,et al.  Ten Simple Rules for Reproducible Computational Research , 2013, PLoS Comput. Biol..

[18]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[19]  Chartchalerm Isarankura-Na-Ayudhya,et al.  Advances in computational methods to predict the biological activity of compounds , 2010, Expert opinion on drug discovery.

[20]  Els Torreele,et al.  Drug development for neglected diseases: a deficient market and a public-health policy failure , 2002, The Lancet.

[21]  Igor V. Filippov,et al.  Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years on , 2011, J. Cheminformatics.

[22]  Vladimir N Uversky,et al.  Intrinsically disordered proteins and novel strategies for drug discovery , 2012, Expert opinion on drug discovery.

[23]  Shuai Li,et al.  ASD v2.0: updated content and novel features focusing on allosteric regulation , 2013, Nucleic Acids Res..

[24]  Julio Saez-Rodriguez,et al.  BioServices: a common Python package to access biological Web Services programmatically , 2013, Bioinform..

[25]  Sean Ekins,et al.  Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situation. , 2012, Drug discovery today.

[26]  Andreas Bender,et al.  Recognizing Pitfalls in Virtual Screening: A Critical Review , 2012, J. Chem. Inf. Model..

[27]  Brian E. Granger,et al.  IPython: A System for Interactive Scientific Computing , 2007, Computing in Science & Engineering.

[28]  F. Pammolli,et al.  The productivity crisis in pharmaceutical R&D , 2011, Nature Reviews Drug Discovery.

[29]  Sorel Muresan,et al.  SARConnect: A Tool to Interrogate the Connectivity Between Proteins, Chemical Structures and Activity Data , 2012, Molecular informatics.

[30]  Sona Warrier,et al.  Reverse docking: a powerful tool for drug repositioning and drug rescue. , 2014, Future medicinal chemistry.

[31]  Lei Chen,et al.  Computational models for predicting substrates or inhibitors of P-glycoprotein. , 2012, Drug discovery today.

[32]  Monika Lessl,et al.  Grants4Targets: an open innovation initiative to foster drug discovery collaborations , 2014, Nature Reviews Drug Discovery.

[33]  Björn Krüger,et al.  The holistic integration of virtual screening in drug discovery. , 2013, Drug discovery today.

[34]  Khusru Asadullah,et al.  What makes a good drug target? , 2011, Drug discovery today.

[35]  D. Judd,et al.  Open Innovation in Drug Discovery research comes of age. , 2013, Drug discovery today.

[36]  C. Ottmann,et al.  Modulators of protein-protein interactions. , 2014, Chemical reviews.

[37]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[38]  J Andrew McCammon,et al.  AutoGrow 3.0: an improved algorithm for chemically tractable, semi-automated protein inhibitor design. , 2013, Journal of molecular graphics & modelling.

[39]  Gábor Imre,et al.  Screen3D: A Novel Fully Flexible High-Throughput Shape-Similarity Search Method , 2014, J. Chem. Inf. Model..

[40]  Shane Weaver,et al.  The importance of the domain of applicability in QSAR modeling. , 2008, Journal of molecular graphics & modelling.

[41]  B. Shoichet,et al.  Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. , 2002, Journal of medicinal chemistry.

[42]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[43]  Shaoyong Lu,et al.  Harnessing Allostery: A Novel Approach to Drug Discovery , 2014, Medicinal research reviews.

[44]  Gerard J. P. van Westen,et al.  Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets , 2011 .

[45]  Gennady Verkhivker,et al.  Integrating Ligand-Based and Protein-Centric Virtual Screening of Kinase Inhibitors Using Ensembles of Multiple Protein Kinase Genes and Conformations , 2012, J. Chem. Inf. Model..

[46]  Apilak Worachartcheewan,et al.  Synthesis, cytotoxicity and QSAR study of N-tosyl-1,2,3,4-tetrahydroisoquinoline derivatives , 2013, Archives of pharmacal research.

[47]  Sean Ekins,et al.  A quality alert and call for improved curation of public chemistry databases. , 2011, Drug discovery today.

[48]  Carole A. Goble,et al.  The Taverna workflow suite: designing and executing workflows of Web Services on the desktop, web or in the cloud , 2013, Nucleic Acids Res..

[49]  Chartchalerm Isarankura-Na-Ayudhya,et al.  A practical overview of quantitative structure-activity relationship , 2009 .

[50]  J Andrew McCammon,et al.  LigMerge: A Fast Algorithm to Generate Models of Novel Potential Ligands from Sets of Known Binders , 2012, Chemical biology & drug design.

[51]  Jean-Louis Reymond,et al.  Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 , 2012, J. Chem. Inf. Model..

[52]  Barend Mons,et al.  Open PHACTS: semantic interoperability for drug discovery. , 2012, Drug discovery today.

[53]  Apilak Worachartcheewan,et al.  Large-scale QSAR study of aromatase inhibitors using SMILES-based descriptors , 2014 .

[54]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[55]  Jianfeng Pei,et al.  Systems biology brings new dimensions for structure-based drug design. , 2014, Journal of the American Chemical Society.

[56]  Michael Habeck,et al.  CSB: a Python framework for structural bioinformatics , 2012, Bioinform..

[57]  Rommie E. Amaro,et al.  AutoGrow: A Novel Algorithm for Protein Inhibitor Design , 2009, Chemical biology & drug design.

[58]  Oakland J. Peters,et al.  Predicting new indications for approved drugs using a proteochemometric method. , 2012, Journal of medicinal chemistry.

[59]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[60]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[61]  Antony J. Williams,et al.  ChemSpider:: An Online Chemical Information Resource , 2010 .

[62]  Tingjun Hou,et al.  Assessing an Ensemble Docking-Based Virtual Screening Strategy for Kinase Targets by Considering Protein Flexibility , 2014, J. Chem. Inf. Model..

[63]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[64]  James Andrew McCammon,et al.  Predictive Power of Molecular Dynamics Receptor Structures in Virtual Screening , 2011, J. Chem. Inf. Model..

[65]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[66]  Edward W. Lowe,et al.  Computational Methods in Drug Discovery , 2014, Pharmacological Reviews.

[67]  Apilak Worachartcheewan,et al.  AutoWeka: toward an automated data mining software for QSAR and QSPR studies. , 2015, Methods in molecular biology.

[68]  Evan Bolton,et al.  PubChem's BioAssay Database , 2011, Nucleic Acids Res..

[69]  Apilak Worachartcheewan,et al.  Predicting antimicrobial activities of benzimidazole derivatives , 2013, Medicinal Chemistry Research.

[70]  E. Jacoby,et al.  Chemogenomics: an emerging strategy for rapid target and drug discovery , 2004, Nature Reviews Genetics.

[71]  Bin Chen,et al.  Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data , 2010, BMC Bioinformatics.

[72]  Daniel J. Blankenberg,et al.  Galaxy: a platform for interactive large-scale genome analysis. , 2005, Genome research.

[73]  Tudor I. Oprea,et al.  The CARLSBAD Database: A Confederated Database of Chemical Bioactivities , 2013, Database J. Biol. Databases Curation.

[74]  Wendy A. Warr,et al.  Fragment-based drug discovery , 2009, J. Comput. Aided Mol. Des..